Results 141 to 150 of about 159,964 (350)

Genomic signature driving preinvasive to invasive processes in stage I lung adenocarcinoma

International Journal of Cancer, EarlyView.
What's New? The progression of lung cancer from minimally invasive adenocarcinoma (MIA) to invasive adenocarcinoma (IA) is a complex process involving molecular and microenvironment changes. Key molecular events that drive the invasion process, however, remain poorly characterized. In this comparison of gene profiles and differentially mutated genes in
Biqin Mou, Yishan Duan, Jing Wang, Tiantian Li, Yuwei Huo, Xia Xiao, Conghui Cui, Zhujun Deng, Qiongxia Hu, Juan Jiang, Yiwei Liang, Sifen Lu, Xintong Tao, Kang Xie, Xinru Xiong, Niu Zhu, Liyun Bi, Faqiang Zhang, Weimin Li, Bojiang Chen   +19 more
wiley   +1 more source

[Biliary tract cancer].

Nihon rinsho. Japanese journal of clinical medicine, 2002
Y, Asanuma, H, Andoh, J, Tanaka, K, Koyama   +3 more
  +7 more sources

Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer

, 2013
Seung Woo Yi, Dae Ryong Kang, Kyung Sik Kim, Mi‐Suk Park, Jinsil Seong, Jeong Youp Park, Seungmin Bang, Si Young Song, Jae Bock Chung, Seung Woo Park   +9 more
openalex   +2 more sources

Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective [PDF]

, 2022
Vincent C. Tam, Ravi Ramjeesingh, Ronald L. Burkes, Eric M. Yoshida, Sarah Doucette, Howard J. Lim   +5 more
openalex   +1 more source

Chemotherapy in biliary tract cancer.

European review for medical and pharmacological sciences, 2010
Biliary Tract Cancer is a rare and aggressive tumor characterized by unresponsiveness to chemotherapy and radiotherapy in the vast majority of cases. Surgery offers the only possibility of a cure, though post-operative disease recurrence is common.
Tonini G, Fratto ME, Vincenzi B, Santini D   +3 more
openaire   +2 more sources

Living at genetic risk: The patient experience of Lynch syndrome

International Journal of Cancer, EarlyView.
Abstract Lynch syndrome is a germline cancer predisposition syndrome caused by a variant in one of four genes. Lynch syndrome places individuals at significantly higher risk for a range of cancers, especially colorectal and endometrial. Depending on which gene is affected, the risk of ovarian, gastric, small bowel, pancreatic, biliary urothelial, brain,
Nicola Reents, Georgina Hoffmann, Kelly Kohut   +2 more
wiley   +1 more source

Genomic profiling in Chinese biliary tract cancer patients with PI3K/AKT/mTOR pathway and RAS gene mutations

, 2019
Jingyu Cao, Weidong Guo, Z. Niu, Zhengzhao Wang, Weixin Hu, Xuexiao Ma, D. Liu, Jian‐Quan Shi, Mudi Yao   +8 more
openalex   +1 more source

The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers [PDF]

, 2020
Christopher Limb, Daniel Liu, Morten T. Venø, Eleanor Rees, Jonathan Krell, Izhar Bagwan, Elisa Giovannetti, Hardev Pandha, Oliver Strobel, Timothy Rockall, Adam E. Frampton   +10 more
openalex   +1 more source

The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence [PDF]

, 2022
Hua Sun, Xiaohui Qi
openalex   +1 more source

Organ‐sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making

International Journal of Cancer, EarlyView.
Abstract Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in ...
Martin Duval, Antoine Dardenne, Thomas Samaille, Leo Mas, Jérémie H. Lefèvre, Xavier Dray, Mathilde Wagner, Romain Cohen, Thierry André   +8 more
wiley   +1 more source